Skip to main content

Research news

News stories from 2026

Bringing research to life at UHB for International Clinical Trials Day 2026

Bringing research to life at UHB for International Clinical Trials Day 2026

In celebration of International Clinical Trials Day 2026, our research and innovation teams hosted their annual research showcase across all four of our hospital sites.

University Hospitals Birmingham secures £1.4 million for new cleanroom manufacturing facility

University Hospitals Birmingham secures £1.4 million for new cleanroom manufacturing facility

University Hospitals Birmingham (UHB) has secured £1.4 million from the National Institute for Health and Care Research (NIHR) to support the development of a new cleanroom manufacturing facility within the Precision Health Technologies Accelerator (PHTA) at Birmingham Health Innovation Campus.

World Asthma Day: ‘Remarkable outcome’ study may lead to burden ease

World Asthma Day: ‘Remarkable outcome’ study may lead to burden ease

A nurse living with asthma tested a new drug which showed that patients could reduce the regularity of medication, lessening the clinical and patient burden.

Pancreatic cancer cell atlas highlights why many promising treatments fail

Pancreatic cancer cell atlas highlights why many promising treatments fail

The most detailed atlas of tumour cells from the deadliest form of pancreatic cancer has been developed by an international team of researchers, and the findings uncover how tumour cells change their behaviour depending on their surroundings—and why many promising treatments fail in standard lab tests.

Join us at our 2026 Research Showcase

Join us at our 2026 Research Showcase

University Hospitals Birmingham is gearing up to celebrate International Clinical Trials Day 2026 with its annual Research Showcase, taking place across all four of our hospital sites.

First patient in Birmingham treated with newly approved therapy for aggressive blood cancer

First patient in Birmingham treated with newly approved therapy for aggressive blood cancer

A 28-year-old patient from Shrewsbury has become the first person in Birmingham to receive a new personalised CAR T-cell therapy, known as obe-cel, at Queen Elizabeth Hospital Birmingham (QEHB), since its approval for NHS use late last year.